BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27142989)

  • 1. Chemical transdifferentiation: closer to regenerative medicine.
    Xu A; Cheng L
    Front Med; 2016 Jun; 10(2):152-65. PubMed ID: 27142989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dedifferentiation, transdifferentiation and cell fusion: in vivo reprogramming strategies for regenerative medicine.
    Pesaresi M; Sebastian-Perez R; Cosma MP
    FEBS J; 2019 Mar; 286(6):1074-1093. PubMed ID: 30103260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Cell Fate for Tissue Regeneration by In Vivo Transdifferentiation.
    de Lázaro I; Kostarelos K
    Stem Cell Rev Rep; 2016 Feb; 12(1):129-39. PubMed ID: 26403511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
    Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
    Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming and transdifferentiation shift the landscape of regenerative medicine.
    Guo J; Wang H; Hu X
    DNA Cell Biol; 2013 Oct; 32(10):565-72. PubMed ID: 23930590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration.
    Jopling C; Boue S; Izpisua Belmonte JC
    Nat Rev Mol Cell Biol; 2011 Feb; 12(2):79-89. PubMed ID: 21252997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules for reprogramming and transdifferentiation.
    Qin H; Zhao A; Fu X
    Cell Mol Life Sci; 2017 Oct; 74(19):3553-3575. PubMed ID: 28698932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reprogramming of somatic cells. Problems and solutions].
    Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
    Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modulation of cell fates: in situ regeneration.
    Qin H; Zhao A; Fu X
    Sci China Life Sci; 2018 Oct; 61(10):1137-1150. PubMed ID: 30099708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simpler twist of fate.
    Eisenstein M
    Nature; 2016 Jun; 534(7607):421-3. PubMed ID: 27306187
    [No Abstract]   [Full Text] [Related]  

  • 12. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Cellular Reprogramming: The Next Generation.
    Srivastava D; DeWitt N
    Cell; 2016 Sep; 166(6):1386-1396. PubMed ID: 27610565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced regeneration--the progress and promise of direct reprogramming for heart repair.
    Addis RC; Epstein JA
    Nat Med; 2013 Jul; 19(7):829-36. PubMed ID: 23836233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward transgene-free induced pluripotent stem cells: lessons from transdifferentiation studies.
    Chua SJ; Casper RF; Rogers IM
    Cell Reprogram; 2011 Aug; 13(4):273-80. PubMed ID: 21599518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming and transdifferentiation - two key processes for regenerative medicine.
    Hybiak J; Jankowska K; Machaj F; Rosik J; Broniarek I; Żyluk A; Hilderman GC; Małecki A; Łos MJ; Urasińska E
    Eur J Pharmacol; 2020 Sep; 882():173202. PubMed ID: 32562801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine.
    Sanges D; Lluis F; Cosma MP
    Adv Exp Med Biol; 2011; 713():137-59. PubMed ID: 21432018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.
    Firas J; Liu X; Lim SM; Polo JM
    Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerative medicine: transdifferentiation in vivo.
    Fu L; Zhu X; Yi F; Liu GH; Izpisua Belmonte JC
    Cell Res; 2014 Feb; 24(2):141-2. PubMed ID: 24343579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical reprogramming and transdifferentiation.
    Xie X; Fu Y; Liu J
    Curr Opin Genet Dev; 2017 Oct; 46():104-113. PubMed ID: 28755566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.